Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly. 

Jarred Younger, PhD - The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 (2017 Conference) (LDN, low dose naltrexone)

People with rheumatological conditions are much more likely to have fibromyalgia than the general population, Lupus in particular was indicated to be the most likely rheumatological condition where fibromyalgia was also present. 

Kent Holtorf, MD - CFS/ME and Fibromyalgia (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's CFS/ME Presentation

Pradeep Chopra, MD - Chronic Pain, Opioids and LDN (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Chopra's Chronic Pain Presentation

LDN Research Trust on Vimeo.

In this presentation Dr Jill Cottel talks about the pharmacology of Low dose naltrexone.

Pradeep Chopra, MD - Chronic Pain (2017 Conference) (LDN, low dose naltrexone)

Management of chronic pain with low dose naltrexone (LDN).

Tom O'Bryan, DC, CCN, DACB - Dietary Triggers of Pain and Inflammation (2017 Conference) (LDN, low dose naltrexone)

This is a very interesting presentation entitled “Dietary Triggers of Pain and Inflammation”, in which Dr Tom O’Bryan discusses how food sensitivities impact on chronic disease and how they can interfere with any therapies offered by the doctor.  

Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)